INTRODUCTION
============

In dentistry, local anesthesia is necessary, especially in the field of oral and maxillofacial surgery. The mechanism of local anesthetics inhibits the transmission of nerve impulses causing temporary loss of sensation at the peripheral organ supplied by the nerve until the anesthetic effect is terminated.

Local anesthetics used in dentistry are divided by structure into 3 classes: ester type, amide type, and saxitoxin and tetrodotoxin type. LD hydrochloride is an amide anesthetic that was developed for use in clinical practice to replace ester anesthetics that were associated with a higher incidence of allergic reactions due to one of their metabolites, para-amino benzoic acid (PABA).

LD has a rapid onset, moderate duration of action, and fewer complications, which facilitate its current widespread use. In clinical practice, LD is commonly used for injection at a 2% concentration. At higher concentrations, it can be used as a topical local anesthetic. Besides pain blocking properties, antimicrobial effects of several local anesthetics containing LD have been reported \[[@B1][@B2][@B3][@B4][@B5][@B6][@B7]\]. Divergent results are due to the drug concentration, type of microorganism tested, method of study and various additives, such as preservatives or vasoconstrictive components such as epinephrine \[[@B7][@B8]\]. Topical local anesthetics are commonly used for application on sensitive areas for the purpose of sample collection, e.g., the cornea or the upper respiratory tract, or site of needle injection to reduce the pain. Antimicrobial properties of topical local anesthetics have been reported \[[@B2][@B3][@B5][@B7][@B9][@B10][@B11][@B12][@B13]\]. In a dental setting, oral injection of local anesthetics may cause tissue damage to some extent at the injection site, thereby increasing the chance of bacteremia due to numerous oral microflora \[[@B14]\].

The use of an antiseptic agent prior to oral injection is still controversial. Instead of using an antiseptic agent to wipe the injection site, most dentists use the topical local anesthetic to block the pain from needle injection. This regimen is supported by the previous in vitro studies that topical anesthetic agents have shown antimicrobial effects and suggested a beneficial role in the prophylaxis of infection \[[@B5][@B8][@B13][@B15]\]. In addition, the local infection or abscess at the site of injection is considered exceptional.

Because oral mucosa is commonly colonized with mixed microbial species as biofilms, the clinical antimicrobial effectiveness may vary depending upon the concentration and type of microorganisms. It is thus important to be aware of the antimicrobial effectiveness in clinical settings. The purpose of this study was to evaluate the antimicrobial effectiveness of 10% LD topical anesthetic spray against oral microflora in both laboratory and clinical settings.

MATERIALS AND METHODS
=====================

1. Volunteers for collection of oral microflora and clinical study
------------------------------------------------------------------

Twenty-two volunteers were recruited for this study. The inclusion criteria included healthy people with same number of teeth on the left and right side of the mouth and the ability to open the mouth for more than 3 min. The exclusion criteria included those with oral lesions on the buccal mucosa, allergies to local anesthesia or chlorhexidine (CHX), the routine use of antibacterial mouthwash and those that received antibiotics within 2 weeks prior to the study.

The study protocol was approved by the Committee for Human Research, the faculty of Dentistry, and the faculty of Pharmacy at Mahidol University (MU-DT/PY-IRB 2014/DT098). The oral microflora was collected from both sides of the buccal mucosa of volunteers using sterile cotton swabs, placed in 2-ml BHI broth, and immediately sent to the microbiology laboratory.

2. In vitro test for antimicrobial effect
-----------------------------------------

In all, the following 6 bacterial strains from the stock cultures of the Oral Microbiology Department, Faculty of Dentistry, Mahidol University, were used to determine the antimicrobial effect: *Escherichia coli* ATCC 25922, *Enterococcus faecalis* ATCC 9433, *Staphylococcus aureus* ATCC 6538, *Streptococcus salivarius* ATCC 19258, *Streptococcus pyogenes* ATCC 19615, and *Streptococcus sanguinis* ATCC 10556. Overnight cultures in brain heart infusion (BHI) broth and oral microflora samples from the volunteers were adjusted to the turbidity of the McFarland standard 0.5 and diluted to 10^3^ to obtain approximately 1.0 × 10^5^CFU/ml. A 100-µl aliquot of bacterial solution was plated on three blood agar plates each. The plate was divided into four quadrants each of which was covered by a filter paper containing a test solution.

The test filter papers (2 × 2 cm^2^) were prepared by suspension in 50 µl of the BHI broth, 0.2% CHX (Faculty of Dentistry, Mahidol University), or 10% LD. After filter papers were air-dried for 10 min, they were placed on the surface of each blood agar quadrant. After 1 min, the papers were removed and the plate was incubated at 37℃ in a CO~2~ incubator for 24 h. The growth of the bacteria on the LD quadrant was observed and compared to the control quadrants.

The BHI and CHX quadrants served as the negative (bacterial growth) and positive (no bacterial growth) controls, respectively. The antimicrobial effects at 2- and 3-min exposure times were evaluated in similar procedures. Bacterial growth on the LD quadrant was presented as the antimicrobial scores shown in [Table 1](#T1){ref-type="table"}. Each experiment was repeated twice to confirm the antimicrobial score.

3. In vivo antimicrobial effectiveness
--------------------------------------

Antimicrobial effectiveness of 10% LD local spray against oral microflora was assessed *in vivo* using the split mouth technique. Each volunteer was evaluated in 4 experiments with varying LD exposure times of 1, 2, and 3 min.

Prior to the experiment, the volunteers rinsed their mouths with sterile normal saline. The filter papers (2 × 2 cm^2^) containing BHI broth or 10% LD were placed on either side of buccal mucosa above the occlusal plane between the permanent mandibular second premolar and the permanent mandibular first molar for 1 min. Then the paper was replaced by the filter paper with BHI broth, size 1.5 × 1.5 cm^2^ for 2 min. The papers were placed on a blood agar plate on the control side (BHI) and the test area (LD) for 2 min.

The plate was incubated at 37℃ in the CO~2~ incubator for 24 h. The density of the bacterial growth in the test area was compared with the control area and recorded as antimicrobial scores (0-4), indicated in [Table 1](#T1){ref-type="table"}. After the washout period of at least 1 day, the volunteers were asked to conduct the experiment at 2 and 3 min exposure times using LD. In addition, antimicrobial effectiveness of 0.2% CHX was also assessed at the exposure time of 2 min.

4. Statistical analysis
-----------------------

The mean values of antimicrobial scores obtained from 22 volunteers at different exposure times (1, 2, and 3 min) were analyzed by the Friedman test using SPSS version 18.0 statistical package for Windows (SPSS Inc. Chicago, IL). The significance level was considered at P \< 0.05.

RESULTS
=======

1. In vitro test for antimicrobial effect of 10% LD topical local anesthesia
----------------------------------------------------------------------------

The antimicrobial effect of 0.2% CHX and 10% LD against six bacterial species was shown in [Table 2](#T2){ref-type="table"}. The in vitro results indicated that CHX could inhibit *E. coli*, *S. salivarius*, *S. viridans*, and *S. aureus*, within 1 min (\> 95% reduction), but it had no effect against *E. faecalis* and *S. pyogenes* even after an exposure time of 3 min. LD was less effective than CHX; within 3 min the growth of *E. coli*, *S. salivarius*, and *S. viridans* was less than 50% and there was no effect against *S. aureus*, *E. faecalis*, and *S. pyogenes*.

Regarding oral microflora, the antimicrobial effect of LD on 22 volunteer samples was shown in [Fig. 1](#F1){ref-type="fig"}. The highest antimicrobial score at the exposure time of 1 min was 2 in 3 volunteers; at 2 min, was 3 in 4 volunteers; and at 3 min, was 3 in 11 volunteers. Antimicrobial effectiveness of 10% LD showed statistically significant differences among exposure times (P \< 0.05). Within 3 min, LD could not completely inhibit oral microflora from any sample. The antimicrobial score of 3 was shown in [Fig. 2](#F2){ref-type="fig"}. In contrast, 0.2% CHX showed a bactericidal effect against all samples (antimicrobial score of 4), as shown in [Fig. 2](#F2){ref-type="fig"}.

2. Antimicrobial effectiveness of 10% LD against the oral microflora on oral mucosa
-----------------------------------------------------------------------------------

Results of antimicrobial effectiveness of 10% LD when applied on buccal mucosa were shown in [Fig. 3](#F3){ref-type="fig"}. The highest antimicrobial score at the exposure time of 1 min was 3 in only 1 volunteer; at 2 min, the score was 3 in 4 volunteers; and at 3 min, the score was 3 in 13 volunteers. Statistical analysis indicated the significant differences of antimicrobial effectiveness of 10% LD among exposure times (P \< 0.05). Within 3 min, both 0.2% CHX and 10% LD could not completely kill oral microflora from any volunteers. The antimicrobial effect against microflora from 4 volunteers was demonstrated in [Fig. 4](#F4){ref-type="fig"}. Subject nos. 1, 2, 3, and 4 showed antimicrobial scores of 2, 0, 3, and 1, respectively.

DISCUSSION
==========

The administration of local anesthesia in dental procedures by needle injection through the oral mucosa may introduce colonized oral microflora into the blood circulation \[[@B9][@B16]\]. Some local anesthetic injections, i.e., buccal infiltration analgesia, conventional intraligamental analgesia, and modified intraligamental analgesia, can cause bacteremia \[[@B14]\]. Another study has shown increases in bacterial levels in the blood stream immediately after local anesthetic injection and the level were decreased subsequently \[[@B17]\]. Nevertheless, antibiotic prophylaxis is recommended prior to some dental treatment, i.e., tooth extraction, root scaling to reduce bacteremia, particularly in immunocompromised patients or patients receiving immunosuppressive therapy. Previous studies reported that prophylactic penicillin G prior to tooth extractions and dental cleaning decreased bacteremia rates \[[@B18][@B19]\].

Several previous studies have shown that local anesthesia also possesses antimicrobial properties. The first observation was made in 1909 and followed by others which studied several anesthetic preparations used in dentistry \[[@B4][@B5][@B6][@B8][@B13][@B20]\]. The studies were conducted in vitro using various microbial species, including oral microflora species and opportunistic pathogens. Pelz et al. tested the antimicrobial activity of seven local anesthetics currently used in dentistry, i.e., Ultracaine D-S (articaine hydrochloride), Carbostesin (bupivacaine hydrochloride), Scandicaine (mepivacaine hydrochloride), Xylonest (prilocaine hydrochloride), Xylocaine (LD hydrochloride), Hostacaine (butanilicaine phosphate), and Novacaine (procaine hydrochloride) against a number of commensal and pathogenic species found in the oral cavity \[[@B8]\]. They determined the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) and found that the MBC values of local anesthetics were lower than the concentration that was routinely used for injection. It suggested that local anesthetics may be able to inhibit microorganisms entering the soft tissue during needle injection.

Topical anesthetics were generally applied on sensitive areas to collect samples or to the injection site in order to block pain. The antimicrobial effect of topical anesthetics in the dental field has been shown to be effective against both oral and non-oral bacteria \[[@B4][@B5][@B7][@B9]\]. Using the agar disc diffusion method, Gocmen et al., compared the antimicrobial effect of 5% LD, 2.5% LD/prilocaine, and 2% mupirocin (an antimicrobial agent) against six bacterial strains: *S. aureus*, *S. epidermidis*, *S. pyogenes*, *E. faecalis*, *Pseudomonas aeruginosa*, and *E. coli* \[[@B13]\]. Both topical local anesthetics were found to be effective against *S. aureus*, *S. epidermidis*, *E. coli*, and *S. pyogenes*, whereas they had no effects on *P. aeruginosa*. Only 5% LD was effective against *E. faecalis*. However, the inhibition zones of both anesthetics were smaller than those of mupirocin.

Our *in vitro* results, in agreement with the previous studies, show differences in susceptibility of selected oral and non-oral bacterial strains to 10% LD. The antimicrobial effect was increased as the exposure time increased from 1 to 3 min. Parr et al. reported that the killing effect of LD was time and dose dependent; gram-negative bacteria were more susceptible than gram-positive bacteria \[[@B15]\]. In the case of mixed oral microflora from buccal mucosa, a higher number of samples with the highest antimicrobial effect was obtained when the exposure time increased from 1 to 3 min. Nevertheless, the short exposure time of 3 min was not enough to inhibit all bacteria. We conducted antimicrobial effectiveness *in vivo* or in other words, evaluated the effect of anesthetic agents against biofilms on oral mucosa at the site of injection which was comprised different species in varying concentrations. We mimicked the clinical situation by placing the filter paper soaked with topical 10% LD spray on the buccal mucosa and determined the antimicrobial effect within the duration of 1--3 min. The imprint technique was used to collect oral biofilms on the buccal mucosa for bacterial culturing.

To our knowledge, this is the first in vivo study which showed the antimicrobial effectiveness of topical local anesthetic spray against mixed microflora of the oral cavity. Our results suggested the 10% LD topical anesthetic spray can reduce the amount of oral biofilms on the buccal mucosa by 60--95% when compared with controls without the anesthetic. According to the results from the laboratory study, the effectiveness in each individual is different owing to the species, concentration, and exposure time. The mechanism of action on microbial survival is not well understood. Some researchers suggested that it may be related to an adverse effect on the bacterial cell wall or cell membrane permeability, which is related to the lipophilic nature of the drug or upon the synthesis of cell membrane precursors \[[@B21]\]. Other suggested mechanisms are the dysfunction of cellular respiration, or the alteration of DNA, RNA, and protein synthesis \[[@B20][@B22]\].

In conclusion, this study demonstrated the antimicrobial activity of 10% LD topical anesthetic spray in vitro and determined its application on buccal mucosa for 3 min could cause a reduction in oral microflora. The antimicrobial effect of local anesthetic use in dentistry may explain the low incidence of local infections and injection abscesses. The factors which interfered with the effectiveness in vivo are the drug concentration, the dilution by saliva, contact time, the number and type of microorganisms present and the presence of mucus. The suggested use of an antiseptic mouthwash to reduce oral bacteria may enhance the antimicrobial effectiveness of subsequent applications of local anesthetic spray. In addition, the use of antibiotic prophylaxis and antiseptic agents in immunocompromised patients should be considered to prevent infections by opportunistic pathogens.
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###### Antimicrobial scores of 10% lidocaine spray by comparing with the growth of negative control (BHI)

![](jdapm-16-17-i001)

  Growth compared to the negative control                                                 Antimicrobial scores
  --------------------------------------------------------------------------------------- ----------------------
  No growth or \> 95% bacterial reduction                                                 4
  Growth density was 60--95% bacterial reduction                                          3
  Growth density was 40--60% bacterial reduction                                          2
  Growth density was 5--40% bacterial reduction                                           1
  Growth density comparable to the negative control or less than 5% bacterial reduction   0

###### Antimicrobial effect of 0.2% chlorhexidine and 10% lidocaine against 6 oral bacterial species

![](jdapm-16-17-i002)

  Bacterial species   Antimicrobial score                   
  ------------------- --------------------- --- --- --- --- ---
  *E. coli*           4                     4   4   3   3   3
  *S. viridans*       4                     4   4   3   3   3
  *S. salivarius*     4                     4   4   1   1   1
  *S. aureus*         4                     4   4   0   0   0
  *E. faecalis*       0                     0   0   0   0   0
  *S. pyogenes*       0                     0   0   0   0   0

Antimicrobial score: 4 = \>95% bacterial reduction, 3 = 60--95% bacterial reduction, 2 = 40--60% bacterial reduction, 1 = 5--40% bacterial reduction, 0 = \<5% bacterial reduction
